This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
R. James Taylor
Advertisement
R. James Taylor, PhD, is CEO and co-founder at Precision Nanosystems.
Articles by R. James Taylor
Advertisement
Latest Updated Articles
Accelerating Genetic Medicine R&D Using MicrofluidicsPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
2
Regulatory Challenges for Global Manufacturing of Vaccines
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
5
